Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac diseaseMichael I. Kulick, Anil K. Bhandari, Shahbudin H. Rahimtoola et al.|American Heart Journal|1988Cited by 108
Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancyJosef Widerhorn, Uri Elkayam, Stefan Bughi et al.|American Heart Journal|1991Cited by 71
Frequency and significance of induced sustained ventricular tachycardia or fibrillation two weeks after acute myocardial infarctionAnil K. Bhandari, Delon Wu, Jeffrey S. Rose et al.|The American Journal of Cardiology|1985Cited by 51
Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardiaPhilip T. Sager, Anil K. Bhandari, Elisabeth Ryzen et al.|American Heart Journal|1990Cited by 43
Decline in inducibility of sustained ventricular tachycardia from two to twenty weeks after acute myocardial infarctionAnil K. Bhandari, Shahbudin H. Rahimtoola, Phillip K. Au et al.|The American Journal of Cardiology|1987Cited by 39